Company’s 36-month beta value is 0.48.Analysts have differing opinions on the stock, with 0 analysts rating it as a “buy,” 0 as “overweight,” 3 as “hold,” and 0 as “sell.”
The public float for CMAX is 2.36M, and currently, short sellers hold a 19.64% ratio of that floaft. The average trading volume of CMAX on November 25, 2024 was 320.84K shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
CMAX) stock’s latest price update
The stock price of CareMax Inc (NASDAQ: CMAX) has dropped by -27.79 compared to previous close of 0.72. Despite this, the company has seen a fall of -40.24% in its stock price over the last five trading days. businesswire.com reported 2024-11-25 that MIAMI–(BUSINESS WIRE)–CareMax, Inc. (NASDAQ: CMAX; CMAXW) (“CareMax” or the “Company”), a leading technology-enabled value-based care delivery system, today announced that it has entered into a “stalking horse” purchase agreement with ClareMedica Health Partners (“ClareMedica”), a leader in value-based primary care serving patients in Florida, pursuant to which ClareMedica will acquire CareMax’s core centers’ assets including a vast majority of CareMax’s operating clinics (the “Core Centers’.
CMAX’s Market Performance
CareMax Inc (CMAX) has experienced a -40.24% fall in stock performance for the past week, with a -67.91% drop in the past month, and a -83.60% drop in the past quarter. The volatility ratio for the week is 24.09%, and the volatility levels for the past 30 days are at 18.84% for CMAX. The simple moving average for the past 20 days is -66.66% for CMAX’s stock, with a -84.69% simple moving average for the past 200 days.
Analysts’ Opinion of CMAX
Many brokerage firms have already submitted their reports for CMAX stocks, with Jefferies repeating the rating for CMAX by listing it as a “Hold.” The predicted price for CMAX in the upcoming period, according to Jefferies is $7.50 based on the research report published on February 26, 2024 of the current year 2024.
UBS, on the other hand, stated in their research note that they expect to see CMAX reach a price target of $1, previously predicting the price at $5. The rating they have provided for CMAX stocks is “Neutral” according to the report published on November 17th, 2023.
Piper Sandler gave a rating of “Neutral” to CMAX, setting the target price at $2 in the report published on November 10th of the previous year.
CMAX Trading at -69.58% from the 50-Day Moving Average
After a stumble in the market that brought CMAX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -97.86% of loss for the given period.
Volatility was left at 18.84%, however, over the last 30 days, the volatility rate increased by 24.09%, as shares sank -68.39% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -78.51% lower at present.
During the last 5 trading sessions, CMAX fell by -43.68%, which changed the moving average for the period of 200-days by -90.28% in comparison to the 20-day moving average, which settled at $1.5578. In addition, CareMax Inc saw -96.52% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for CMAX
Current profitability levels for the company are sitting at:
- -0.47 for the present operating margin
- 0.39 for the gross margin
The net margin for CareMax Inc stands at -1.0. The total capital return value is set at 4.92. Equity return is now at value -328.42, with -97.55 for asset returns.
Based on CareMax Inc (CMAX), the company’s capital structure generated 1.49 points at debt to capital in total, while cash flow to debt ratio is standing at -0.12. The debt to equity ratio resting at -3.04. The interest coverage ratio of the stock is -5.27.
Currently, EBITDA for the company is -590.46 million with net debt to EBITDA at -0.74. When we switch over and look at the enterprise to sales, we see a ratio of 0.64. The receivables turnover for the company is 8.05for trailing twelve months and the total asset turnover is 1.73. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.23.
Conclusion
In a nutshell, CareMax Inc (CMAX) has experienced a bad performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
